Clinical Trials Directory

Trials / Completed

CompletedNCT04702529

Treatment of Fibrotic Scars With Rapid Acoustic Pulse (RAP) Device

Soliton's Rapid Acoustic Pulse (RAP) Device for the Treatment of Fibrotic Scars: Multi-Treatment Proof-of-Concept Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Soliton · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

A multi-treatment proof of concept clinical study is to evaluate the safety, and efficacy of multiple treatments with Soliton's Rapid Acoustic Pulse (RAP) device for the improvement in the appearance of fibrotic scars

Detailed description

Soliton's Rapid Acoustic Pulse(RAP) device is an electrohydraulic (EH) device using Soliton's Rapid Acoustic Pulse (RAP) technology developed to minimize the appearance of scars through both micro-disruption of the scar matrix leading to scar remodeling and down regulation of the 'fibrotic fibroblasts'

Conditions

Interventions

TypeNameDescription
DEVICETreatment of hypertrophic scars (Soliton's Rapid Acoustic Pulse (RAP) Device)Administration of 3 Rapid Acoustic Pulse (RAP) treatments

Timeline

Start date
2022-06-22
Primary completion
2023-08-31
Completion
2023-08-31
First posted
2021-01-11
Last updated
2024-12-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04702529. Inclusion in this directory is not an endorsement.

Treatment of Fibrotic Scars With Rapid Acoustic Pulse (RAP) Device (NCT04702529) · Clinical Trials Directory